Chemical Identification of Cacumen Platycladi by Molecular Networking and its Anti-colorectal Cancer Effects

被引:0
|
作者
Li, Tianjiao [1 ,2 ,3 ]
Yang, Xinxin [1 ,2 ,3 ]
Bao, Yongrui [1 ,2 ,3 ]
Wang, Shuai [1 ,2 ,3 ]
Su, Kaiqiang [1 ,2 ,3 ]
Meng, Xiansheng [1 ,2 ,3 ]
机构
[1] Liaoning Univ Tradit Chinese Med, Sch Pharm, Shenyang 116600, Peoples R China
[2] Liaoning Multidimens Anal Tradit Chinese Med Tech, Dalian 116600, Peoples R China
[3] Liaoning Prov Modern Chinese Med Res Engn L*b, Dalian 116600, Peoples R China
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2023年 / 42卷
关键词
anti-colorectal cancer; cacumen platycladi; chemical profiles; molecular networking; UHPLC-QTOF-MS; PHENOLIC-COMPOUNDS; RUBRA SIEB; MS/MS; ORIENTALIS; FLAVONOIDS; PROFILES; EXTRACTS; LEAVES; FRUITS; ZUCC;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cacumen Platycladi (CP) has been utilized in China as a traditional medicine to prevent and treat haemorrhage diseases. However, the chemical profiling and anti-colorectal cancer effects of CP have not yet been fully decoded. In this study, the comprehensive profiling and characterizing of multi-components of CP were performed by applying an untargeted UHPLC-QTOF-MS-based multi-informative molecular networking strategy. 180 compounds were unambiguously or reasonably identified, including flavonoids, flavonoid glycosides, phenolic acids, phenolic glycosides, lignans, and so on. Some of them were previously unreported in CP. Simultaneously, the anti-colorectal cancer activity of various solvent extracts of CP was examined. The extracts of CP have better inhibition effects on the proliferation of HT-29, Caco-2 and SW620 human colon cancer cells. Collectively, our results can serve as references for targeted extracting potential active compounds of CP on colorectal cancer, and pave the way to clarify the material basis of efficacy.
引用
收藏
页码:72 / 82
页数:11
相关论文
共 50 条
  • [31] Anti-Colorectal Cancer Mechanisms of Formononetin Identified by Network Pharmacological Approach
    Zhang, Lei
    Gong, Yizhen
    Wang, Shuai
    Gao, Feng
    MEDICAL SCIENCE MONITOR, 2019, 25 : 7709 - 7714
  • [32] Genotoxic agents conjugated inhibitors of glucose transporter for anti-colorectal cancer
    Chang, Chun-Kai
    Yang, Hui-Yi
    Liang, Pi-Hui
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [33] Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex
    Shnyder, Steve D.
    Fu, Ying
    Habtemariam, Abraha
    van Rijt, Sabine H.
    Cooper, Patricia A.
    Loadman, Paul M.
    Sadler, Peter J.
    MEDCHEMCOMM, 2011, 2 (07) : 666 - 668
  • [34] Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data
    Li, Rong
    Ma, Xiuying
    Song, Yingqi
    Zhang, Yuanyuan
    Xiong, Wenbi
    Li, Li
    Zhou, Liming
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (07) : 11265 - 11273
  • [35] Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling in vitro
    Meng, Mingjing
    Tan, Jincheng
    Chen, Hui
    Shi, Zhiqiang
    Kwan, Hiu-Yee
    Su, Tao
    HELIYON, 2023, 9 (08)
  • [36] Medicinal plants with anti-colorectal cancer bioactive compounds: Potential game-changers in colorectal cancer management
    Macharia, John M.
    Mwangi, Ruth W.
    Rozmann, Nora
    Zsolt, Kaposztas
    Varjas, Timea
    Uchechukwu, Paschal O.
    Wagara, Isabel N.
    Raposa, Bence L.
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [37] EXVIVO PERFUSION OF HUMAN-COLON WITH MONOCLONAL ANTI-COLORECTAL CANCER ANTIBODIES
    SEARS, HF
    HERLYN, D
    HERLYN, M
    STEPLEWSKI, Z
    GROTZINGER, P
    KOPROWSKI, H
    CANCER, 1982, 49 (06) : 1231 - 1235
  • [38] Glycomodification and characterization of anti-colorectal cancer immunotherapeutic monoclonal antibodies in transgenic tobacco
    So, Yangkang
    Lee, Kyung-Jin
    Kim, Deuk-Su
    Lee, Jeong-Hwan
    Oh, Doo-Byoung
    Hwang, Kyung-A
    Ko, Kinarm
    Choo, Young-Kug
    Ko, Kisung
    PLANT CELL TISSUE AND ORGAN CULTURE, 2013, 113 (01) : 41 - 49
  • [39] Discovery and mechanism studies of a novel ATG4B inhibitor Ebselen by drug repurposing and its anti-colorectal cancer effects in mice
    Huazhong Xie
    Pengfei Qiang
    Yao Wang
    Fan Xia
    Peiqing Liu
    Min Li
    Cell & Bioscience, 12
  • [40] Discovery and mechanism studies of a novel ATG4B inhibitor Ebselen by drug repurposing and its anti-colorectal cancer effects in mice
    Xie, Huazhong
    Qiang, Pengfei
    Wang, Yao
    Xia, Fan
    Liu, Peiqing
    Li, Min
    CELL AND BIOSCIENCE, 2022, 12 (01):